LaserGen, Inc.

LaserGen, Inc. specializes in innovative molecular biology solutions, focusing on advanced technologies that enhance genetic research and diagnostics through precise and efficient methods. Founded in 2002 and headquartered in Houston, US, LaserGen, Inc. develops advanced molecular biology solutions.

The company was acquired by Agilent Technologies Inc. in May 2018, which highlights its strategic growth and collaboration with industry leaders. LaserGen has engaged in three investment deals. LaserGen, Inc.

offers a range of molecular biology products and services that enhance genetic research and diagnostics. Their solutions are designed for precision and efficiency, catering to laboratories and research institutions in various applications, including genomics and biomarker discovery. The company’s technology supports essential workflows in genetic testing and clinical diagnostics. LaserGen generates revenue primarily through B2B transactions with research institutions, laboratories, and pharmaceutical companies.

Their model includes sales of innovative molecular biology solutions and ongoing service agreements to maintain and optimize their products. This structured approach ensures a steady revenue stream aligned with the needs of their diverse clientele. LaserGen, Inc. plans to leverage its recent acquisition by Agilent Technologies Inc.

to expand its product offerings and market reach. The company is focused on developing new molecular biology products aimed for release in the coming years. Additionally, LaserGen is exploring expansion into key global markets, particularly in Europe and Asia-Pacific, to enhance their footprint and customer access. The acquisition funds will be utilized to support these initiatives, driving innovation and operational growth.